UA25669C2 - Средство для лечения гнойных ран "липовит" - Google Patents
Средство для лечения гнойных ран "липовит" Download PDFInfo
- Publication number
- UA25669C2 UA25669C2 UA97126448A UA97126448A UA25669C2 UA 25669 C2 UA25669 C2 UA 25669C2 UA 97126448 A UA97126448 A UA 97126448A UA 97126448 A UA97126448 A UA 97126448A UA 25669 C2 UA25669 C2 UA 25669C2
- Authority
- UA
- Ukraine
- Prior art keywords
- treatment
- agent
- wound
- active substance
- leob
- Prior art date
Links
- 208000027418 Wounds and injury Diseases 0.000 title claims abstract description 39
- 206010052428 Wound Diseases 0.000 title claims abstract description 38
- 239000013543 active substance Substances 0.000 claims abstract description 15
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 14
- 239000000284 extract Substances 0.000 claims abstract description 10
- 239000000945 filler Substances 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000019271 petrolatum Nutrition 0.000 claims abstract description 6
- 239000008213 purified water Substances 0.000 claims abstract description 5
- 229940038481 bee pollen Drugs 0.000 claims description 10
- -1 polyethylene Polymers 0.000 claims description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 6
- 235000020071 rectified spirit Nutrition 0.000 claims description 6
- 239000004698 Polyethylene Substances 0.000 claims description 5
- 229920000573 polyethylene Polymers 0.000 claims description 5
- PLXUFYVBQPIQQH-UHFFFAOYSA-N butoxymethoxybenzene Chemical compound CCCCOCOC1=CC=CC=C1 PLXUFYVBQPIQQH-UHFFFAOYSA-N 0.000 claims description 4
- 229940099259 vaseline Drugs 0.000 claims description 3
- 238000012876 topography Methods 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 abstract description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 9
- 239000004264 Petrolatum Substances 0.000 abstract 2
- 229940066842 petrolatum Drugs 0.000 abstract 2
- 230000000694 effects Effects 0.000 description 18
- 238000000034 method Methods 0.000 description 15
- 239000000203 mixture Substances 0.000 description 15
- 239000003814 drug Substances 0.000 description 14
- 230000008569 process Effects 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 13
- 229940079593 drug Drugs 0.000 description 10
- 239000002674 ointment Substances 0.000 description 9
- 230000000144 pharmacologic effect Effects 0.000 description 9
- 239000012071 phase Substances 0.000 description 9
- 230000029663 wound healing Effects 0.000 description 9
- 239000000126 substance Substances 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 7
- 235000012907 honey Nutrition 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 235000021466 carotenoid Nutrition 0.000 description 5
- 150000001747 carotenoids Chemical class 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 244000062730 Melissa officinalis Species 0.000 description 4
- 235000010654 Melissa officinalis Nutrition 0.000 description 4
- 235000013871 bee wax Nutrition 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 239000000865 liniment Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000241413 Propolis Species 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 238000009341 apiculture Methods 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 150000002191 fatty alcohols Chemical class 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 229940069949 propolis Drugs 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 206010036940 Prostatic adenoma Diseases 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 230000002528 anti-freeze Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229940126601 medicinal product Drugs 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 244000005706 microflora Species 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- BSWWXRFVMJHFBN-UHFFFAOYSA-N 2,4,6-tribromophenol Chemical compound OC1=C(Br)C=C(Br)C=C1Br BSWWXRFVMJHFBN-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010002153 Anal fissure Diseases 0.000 description 1
- 208000016583 Anus disease Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241000490050 Eleutherococcus Species 0.000 description 1
- 208000009531 Fissure in Ano Diseases 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 240000000950 Hippophae rhamnoides Species 0.000 description 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 206010037569 Purulent discharge Diseases 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000022440 X-linked sideroblastic anemia 1 Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 230000001195 anabolic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 239000003659 bee venom Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229940088623 biologically active substance Drugs 0.000 description 1
- 230000001764 biostimulatory effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000013507 chronic prostatitis Diseases 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000000403 immunocorrecting effect Effects 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000032630 lymph circulation Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012907 medicinal substance Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000000936 membranestabilizing effect Effects 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 1
- 229960001907 nitrofurazone Drugs 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000079 pharmacotherapeutic effect Effects 0.000 description 1
- NCAIGTHBQTXTLR-UHFFFAOYSA-N phentermine hydrochloride Chemical compound [Cl-].CC(C)([NH3+])CC1=CC=CC=C1 NCAIGTHBQTXTLR-UHFFFAOYSA-N 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000009030 positive regulation of metabolic process Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 210000003079 salivary gland Anatomy 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 231100000075 skin burn Toxicity 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000563 toxic property Toxicity 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000003357 wound healing promoting agent Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Средство для лечения гнойных ран, содержащее активное вещество на основе пчелиного обножья и наполнитель с содержанием спирта этилового ректификата и воды очищенной, в котором активное вещество - липофильный экстракт пчелиной цветочной пыльцы, а наполнитель дополнительно содержит масло вазелиновое, эмульгатор № 1, полиэтиленоксид-400, бутилоксианизол, бронитрол, при соотношении компонентов, масс. %: Липофильный экстракт пчелиной цветочной пыльцы 2,9-3,1 Масло вазелиновое 9,8-10,2 Эмульгатор № 1 8,8-9,2 Полиэтиленоксид-400 9,8-10,2 Бутилоксианизол 0,145-0,155 Бронитрол 0,095-0,105 Спирт этиловый ректификат 4,9-5,1 Вода очищенная до 100,0.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UA97126448A UA25669C2 (ru) | 1997-12-30 | 1997-12-30 | Средство для лечения гнойных ран "липовит" |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UA97126448A UA25669C2 (ru) | 1997-12-30 | 1997-12-30 | Средство для лечения гнойных ран "липовит" |
Publications (1)
Publication Number | Publication Date |
---|---|
UA25669C2 true UA25669C2 (ru) | 2004-04-15 |
Family
ID=61021890
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UA97126448A UA25669C2 (ru) | 1997-12-30 | 1997-12-30 | Средство для лечения гнойных ран "липовит" |
Country Status (1)
Country | Link |
---|---|
UA (1) | UA25669C2 (ru) |
-
1997
- 1997-12-30 UA UA97126448A patent/UA25669C2/ru unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7867522B2 (en) | Method of wound/burn healing using copper-zinc compositions | |
JP4564471B2 (ja) | 外用に適する組成物 | |
CA2301009C (en) | Skin care compositions and use | |
US5639740A (en) | Topical moisturizing composition and method | |
KR20100016450A (ko) | 피부 외용제 조성물 | |
JP7193662B2 (ja) | ペプチド成分の皮膚再生および治癒混合物とその使用 | |
JP6130441B2 (ja) | 創傷、皮膚障害および脱毛を治療するための1以上のハマアズキ、ココヤシまたはモモタマナ抽出物 | |
RU2470640C1 (ru) | Средство для лечения воспалительных заболеваний полости рта и способ лечения воспалительных заболеваний полости рта | |
JP3881411B2 (ja) | 外用に適する組成物 | |
RU2405534C1 (ru) | Крем-гель противоугревой | |
UA25669C2 (ru) | Средство для лечения гнойных ран "липовит" | |
RU2681850C1 (ru) | Средство, стимулирующее репарацию тканей при термических ожогах | |
EP1688145A1 (en) | Methods and compositions for treating psoriasis | |
RU2159113C1 (ru) | Средство, обладающее противовоспалительным, антисептическим и регенераторным действием | |
RU2295958C1 (ru) | Фармацевтический состав для лечения грибковых заболеваний и способ его получения | |
RU2695349C1 (ru) | Ранозаживляющая противорубцовая мазь на основе капусты огородной (brassica oleracea) | |
RU2128990C1 (ru) | Мазь противовоспалительная и ранозаживляющая "вундэхил" | |
Khan et al. | Formulation and evaluation of derma heal cream against wound and burn healing activity in streptozotocin-induced diabetic Wistar albino rat | |
RU2794958C2 (ru) | Композиция ранозаживляющего действия | |
RU2097017C1 (ru) | Средство для стимулирования роста волос и кожной регенерации | |
RU2033163C1 (ru) | Средство, стимулирующее ранозаживление и/или улучшающее обмен веществ в покровных тканях | |
RU2687485C1 (ru) | Средство для терапии раневых и ожоговых поражений кожи | |
RU2740450C1 (ru) | Стоматологический гель с адаптогеном для лечения воспалительных заболеваний пародонта | |
RU2400214C1 (ru) | Средство косметическое для ухода за кожей с заживляющим и регенерирующим действием | |
UA125010C2 (uk) | Композиція олій для догляду за шкірою з регенеруючими та протизапальними властивостями |